P1879Empagliflozin reduces mortality and hospitalisation for heart failure irrespective of cardiovascular risk score at baseline. (28th August 2018) - Fitchett, D; Inzucchi, S E; Cannon, C P; McGuire, D K; Johansen, O E; Sambevski, S; Hehnke, U; George, J; Zinman, B